-
Geneticin: Cell Selection and Assay Workflows
2026-09-08
Geneticin supports reproducible stable-cell selection while also enabling carefully controlled antiviral and mechanistic assays. This workflow-focused guide connects G418 selection to CLK2–BRCA1 platinum-resistance models without confusing selection pressure with biological treatment effects.
-
Arsenic Neurotoxicity, MMP-2/9, and BBB Injury
2026-09-08
A 2024 mouse study links chronic sodium arsenite exposure with cognitive impairment, blood–brain barrier disruption, and hippocampal neuronal apoptosis through an MMP-2/MMP-9-associated pathway. Its doxycycline intervention provides pharmacological evidence that preserving tight-junction integrity may reduce arsenic-related neurological injury, while also highlighting the limits of broad MMP inhibition as a mechanistic test.
-
ABT-263 Workflow for Apoptosis and Metabolism
2026-09-07
ABT-263 (Navitoclax) combines high-affinity Bcl-2 family inhibition with a practical platform for linking mitochondrial metabolism to apoptosis. This workflow shows how to pair apoptosis assays, optical redox imaging, and cell-state measurements so metabolic shifts are not mistaken for cell death.
-
Phosphatase Inhibitor Cocktail: Signaling Guide
2026-09-07
Discover how the Phosphatase Inhibitor Cocktail supports protein phosphorylation preservation in endometrial signaling studies. This guide connects K1015 sample handling with the Angiogenin–rRNA mechanism reported in ovarian-stimulation research and clarifies what the reagent can—and cannot—prove.
-
U-73122 for Reliable PLC Signaling Assays
2026-09-05
This scenario-based guide explains how U-73122, SKU B3422, can support reproducible PLC signaling pathway modulation in calcium flux, chemotaxis, viability, and invasion workflows. It connects product specifications with published breast cancer evidence and practical controls for interpreting signaling effects without confusing them with nonspecific cytotoxicity.
-
Cholesterol Hinders LNP Intracellular Trafficking
2026-09-04
A 2025 study developed a sensitive imaging platform to follow nucleic acid-loaded lipid nanoparticles through endocytic compartments. Its results indicate that increasing cholesterol, rather than ionizable-lipid content alone, promotes aggregation in peripheral early endosomes, limiting downstream trafficking and reducing cargo delivery.
-
Nicotinamide Riboside Chloride in iPSC-RGC Models
2026-09-04
Use Nicotinamide Riboside Chloride (NIAGEN) as a controlled NAD+ metabolism variable in chemically defined retinal ganglion cell workflows. This article shows how to preserve the reference differentiation framework while testing energy-state effects, improving assay interpretation, and troubleshooting reproducibility.
-
A Multimodal iPSC Platform for Cystic Fibrosis
2026-09-03
The reference study develops patient-derived airway epithelial models from induced pluripotent stem cells carrying common and rare CFTR variants. By combining three-dimensional forskolin-induced swelling with planar polarized mucociliary cultures, it demonstrates genotype-specific differences in baseline CFTR function and modulator response, creating a practical platform for rare-variant drug testing.
-
Oxaliplatin, CDK1, and PARP Inhibition in Gastric Cancer
2026-09-03
This preprint identifies a CDK1–PARP vulnerability that may help overcome Oxaliplatin resistance in gastric cancer, including tumors with intact BRCA1 function. Using patient-derived organoids, resistant gastric cancer cell models, sequencing, and xenograft experiments, the authors report that combining Oxaliplatin with olaparib can restore tumor-cell sensitivity.
-
AI-10-49 Workflow for CBFβ-SMMHC Leukemia Research
2026-09-02
AI-10-49 enables mechanism-driven studies of RUNX1 reactivation, transcriptional remodeling, and leukemia-cell survival in inv(16) models. This practical workflow connects target engagement with chromatin immunoprecipitation, MYCN/eIF4G1 analysis, functional assays, and in vivo validation.
-
EGTA: Calcium Chelation in Cell Assays
2026-09-02
A scenario-based guide to using EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid), SKU B7195, to investigate calcium-dependent variability in viability, proliferation, cytotoxicity, and apoptosis assays. The article covers solubility controls, protocol design, interpretation, and evidence-based reagent selection.
-
DR5 Agonists, PD-L1 Stabilization, and Tumor Immunity
2026-09-01
Mondal et al. identified an unexpected immune-evasion consequence of DR5 agonist antibodies: caspase-8 signaling can activate ROCK1 and impair proteasome function, stabilizing tumor-cell PD-L1. The study supports combining death-receptor agonism with strategies that interrupt the DR5–ROCK1–PD-L1 axis rather than treating apoptotic tumor debulking as immunologically neutral.
-
ApexPrep DNA Plasmid Miniprep Kit for AML Research
2026-09-01
Build cleaner cloning, sequencing, knockdown, rescue, and interaction-assay workflows around the ApexPrep DNA Plasmid Miniprep Kit. Its alkaline lysis format supports high- and low-copy vectors while delivering up to 30 μg of molecular biology grade plasmid DNA from 1–5 mL cultures, making it a practical bridge between construct design and AML mechanism studies.
-
Geneticin Workflows for Stable Cancer Cell Models
2026-08-31
Geneticin, also called G418 Sulfate, converts successful gene delivery into a selectable, expandable cell population for mechanistic cancer assays. This guide connects dependable G418 selection with CLK2–BRCA1 platinum-resistance studies and a distinct, context-dependent Dengue virus inhibition workflow.
-
AY 9944 Dihydrochloride: DHCR7 Research Guide
2026-08-31
AY 9944 dihydrochloride is a selective DHCR7 inhibitor that blocks the conversion of 7-dehydrocholesterol to cholesterol. Product data report a 13 nM IC50 against recombinant human DHCR7, while a 2026 grass-carp study provides in vivo genetic evidence connecting dhcr7 disruption with stronger antiviral resistance.